Sort
64,565 grants matching “drug discovery”
Development of SecA as an Antimicrobial Target
$530,161Cubist Pharmaceuticals, Inc. · R44 · FY2002 · AI
Defining a pathway for mitochondrial heme trafficking
$530,159Dennis J Stuehr · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · GM
Synthesis and Optimization of the Aleutianamine Class of Alkaloids
$530,142Mark T Hamann · Medical University Of South Carolina · R01 · FY2024 · GM
Mechanism by which ketogenic diet uncouples tumor growth and overall survival
$530,122Tobias Janowitz · Cold Spring Harbor Laboratory · R37 · FY2024 · CA
Administrative Core
$530,052Prakash S. Nagarkatti · University Of South Carolina At Columbia · P20 · FY2018 · GM
1/7 Psychiatric Genomics Consortium: Finding actionable variation
$530,018Patrick F Sullivan · Univ Of North Carolina Chapel Hill · U01 · FY2020 · MH
Promotion of retinal vascular hyperpermeability and macular edema by ANGPTL4
$530,014Silvia V Montaner · University Of Maryland Baltimore · R01 · FY2016 · EY
Chirality Transfer in Mixed Cation Two-Dimensional Organic-Inorganic Hybrid Perovskites
$530,000Liang Yan · University Of North Carolina At Chapel Hill · · FY2024 · MPS
Administrative Core
$529,990Prakash S. Nagarkatti · University Of South Carolina At Columbia · P20 · FY2021 · GM
Identification of Chemical Probes for the Orphan Nuclear Receptor NR2F6
$529,984Laura A Solt · Scripps Florida · R01 · FY2019 · CA
In vivo methods for preclinical analysis of cognitive therapies for schizophrenia
$529,970Jonathan Max Levenson · Galenea Corporation · RC1 · FY2009 · MH
Discovery and development of potent inhibitors of Jun N-terminal kinase for non-hormonal treatment of endometriosis and associated pain
$529,931Diana Monsivais · Baylor College Of Medicine · R01 · FY2025 · HD
Low cost custom synthesis microarray
$529,928Erdogan Gulari · Biodiscovery, Llc · R42 · FY2010 · GM
Preclinical microphysiological tumor models for nuclear medicine
$529,906Guillem Pratx · Stanford University · R01 · FY2023 · CA
Identification of Pathways that can be Targeted for the Development of Novel Therapies for MRSA
$529,903Eleftherios Mylonakis · Massachusetts Eye And Ear Infirmary · P01 · FY2015 · AI
ALZHEIMERS RESEARCH PROJECT: Alzheimer's disease drug development
$529,901Nigel H. Greig · National Institute On Aging · ZIA · FY2025 · AG
Macrofilaricidal Aminoacyl-tRNA Synthetase Inhibitors
$529,866Michigan State University · U01 · FY2002 · AI
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
$529,860Prince Joseph Kannankeril · Vanderbilt University · R01 · FY2013 · HL
REST-MED12 Pathways in the Regulation of Estrogen - Progesterone Sensitivity in Uterine Leiomyoma
$529,820Vargheese Mani Chennathukuzhi · University Of Kansas Medical Center · R01 · FY2025 · HD
Phase I Studies of Targeted Anti-Cancer Therapies
$529,795Razelle Kurzrock · University Of Tx Md Anderson Can Ctr · U01 · FY2007 · CA
Identification of Rev-Erb alpha/beta nuclear receptor modulators
$529,751Fraydoon Rastinejad · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · DK
Biology and Engineering of Botulinum Neurotoxins.
$529,745Min Dong · Boston Children'S Hospital · R01 · FY2025 · NS
Phase I Studies of Targeted Anti-Cancer Therapies
$529,725Razelle Kurzrock · University Of Tx Md Anderson Can Ctr · U01 · FY2006 · CA
INSECT GLUTAMATE RECEPTORS AS NOVEL INSECTICIDE TARGETS
$529,676Cambria Biosciences, Llc · U01 · FY2004 · AI
Computer Modeling of G Protein-Coupled Receptors
$529,675Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK